Bazedoxifene/Conjugated Estrogen

DRUG4 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer, University of North Carolina, Chapel Hill

Conditions

DepressionEndometrial HyperplasiaOsteoporosisPerimenopausal DisorderVaginal AtrophyVasomotor Symptoms Associated With Menopause

Phase 3

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

CompletedNCT00234819

Wyeth is now a wholly owned subsidiary of PfizerVasomotor Symptoms Associated With Menopause

Start: 2005-10-31End: 2007-02-28Target: 325Updated: 2007-12-28

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

CompletedNCT00238732

Wyeth is now a wholly owned subsidiary of PfizerVaginal Atrophy

Start: 2005-10-31End: 2007-03-31Target: 650Updated: 2007-12-28

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

CompletedNCT00242710

PfizerEndometrial Hyperplasia, Osteoporosis

Start: 2005-09-30End: 2008-09-30Updated: 2013-12-20

Phase 4

Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause

CompletedNCT03740009

University of North Carolina, Chapel HillDepression, Perimenopausal Disorder

Start: 2019-01-02End: 2021-05-17Updated: 2022-05-10

Related Papers

Characterizing the spectrum of distress symptoms in midlife women with perimenopausal depression.

2025-09-03

Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.

2017-03-2227 citations

Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials

Journal of Women s Health2016-09-2712 citations